Su-Jun Lee

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Infectious Diseases

Top Venues

Journal of personalized medicine

Pharmaceuticals (Basel, Switzerland)

Pharmacogenomics and personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ghayda' Alhammadin, Yazun Jarrar, Abdalla Madani, Su-Jun Lee
Exploring the Influence of VDR Genetic Variants TaqI , ApaI , and FokI on COVID-19 Severity and Long-COVID-19 Symptoms. Journal of personalized medicine 13 (12) (2023)
Ghayda' Alhammadin, Yazun Jarrar, Abdalla Madani, Su-Jun Lee
Exploring the Influence of VDR Genetic Variants TaqI , ApaI , and FokI on COVID-19 Severity and Long-COVID-19 Symptoms. Journal of personalized medicine 13 (12) (2023)
Hee Young Cho, Sangzin Ahn, Yong-Soon Cho, Su-Kil Seo, Dong-Hyun Kim, Jae-Gook Shin, Su-Jun Lee
CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Hee Young Cho, Sangzin Ahn, Yong-Soon Cho, Su-Kil Seo, Dong-Hyun Kim, Jae-Gook Shin, Su-Jun Lee
CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Hee Young Cho, Sangzin Ahn, Yong-Soon Cho, Su-Kil Seo, Dong-Hyun Kim, Jae-Gook Shin, Su-Jun Lee
CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Hee Young Cho, Sangzin Ahn, Yong-Soon Cho, Su-Kil Seo, Dong-Hyun Kim, Jae-Gook Shin, Su-Jun Lee
CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Yazun Jarrar, Sara Abudahab, Ghasaq Abdul-Wahab, Dana Zaiter, Abdalla Madani, Sara J Abaalkhail, Dina Abulebdah, Hussam Alhawari, Rami Musleh, Su-Jun Lee
Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation. Pharmacogenomics and personalized medicine 16 (2023)
Yazun Bashir Jarrar, Su-Jun Lee
Demand for Pharmacogenomics and Personalized Medicine in the United Arab Emirates. Journal of personalized medicine 12 (1) (2022)
Hussam H Alhawari, Yazun Bashir Jarrar, Dina Abulebdah, Sara J Abaalkhail, Marah Alkhalili, Sura Alkhalili, Hussein H Alhawari, Munther Momani, Mohammed N Obeidat, Rand K Fram, Mohammad A Salahat, Su-Jun Lee
Effects of Vitamin D Receptor Genotype on Lipid Profiles and Retinopathy Risk in Type 2 Diabetes Patients: A Pilot Study. Journal of personalized medicine 12 (9) (2022)
MyeongJin Yi, Masahiko Negishi, Su-Jun Lee
Estrogen Sulfotransferase (SULT1E1): Its Molecular Regulation, Polymorphisms, and Clinical Perspectives. Journal of personalized medicine 11 (3) (2021)
Su-Jun Lee
Advances in Personalized Medicines along with Functional Genomics and Pharmacogenomics. Journal of personalized medicine 11 (10) (2021)
Malek Zihlif, Amer Imraish, Baeth Moh'd Al-Rawashdeh, Aya Qteish, Raihan Husami, Rawand Husami, Farah Tahboub, Yazun Bashir Jarrar, Su-Jun Lee
The Association of IgE Levels with ADAM33 Genetic Polymorphisms among Asthmatic Patients. Journal of personalized medicine 11 (5) (2021)
Yazun Bashir Jarrar, Su-Jun Lee
The Functionality of UDP-Glucuronosyltransferase Genetic Variants and their Association with Drug Responses and Human Diseases. Journal of personalized medicine 11 (6) (2021)
Arulkumar Nagappan, Su Bum Park, Su-Jun Lee, Yuseok Moon
Mechanistic Implications of Biomass-Derived Particulate Matter for Immunity and Immune Disorders. Toxics 9 (2) (2021)